A carregar...
Novel aspects of antiplatelet therapy in cardiovascular disease
Antiplatelet therapy is a cornerstone in the secondary prophylaxis of adverse cardiovascular events such as myocardial infarction and stroke. The cyclooxygenase inhibitor aspirin remains the most frequently prescribed antiplatelet drug, followed by adenosine diphosphate P2Y(12) receptor blockers. Gl...
Na minha lista:
| Publicado no: | Res Pract Thromb Haemost |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6046593/ https://ncbi.nlm.nih.gov/pubmed/30046748 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rth2.12115 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|